Inactivating NOTCH1 mutations have also been detected in OSCC in 11–15% Caucasian patients [11,13,14,15] and more than 40% of Chinese patients [12], being the second most frequently mutated gene in HNSCC after TP53 [11,14,15]. The gene discussed is NOTCH1; the disease is head and neck squamous cell carcinoma.